Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins
about
Important Role of the IL-32 Inflammatory Network in the Host Response against Viral InfectionHepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1 and Stimulates the Synthesis of Vascular Endothelial Growth FactorCyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatmentEffect of resveratrol on alcohol-induced mortality and liver lesions in miceHuman viruses and cancer.Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cellsGreen tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation.Viral hepatocarcinogenesis.Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoterImmunomodulatory effects of transforming growth factor-β in the liver.Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesisInhibition of HCV 3a core gene through Silymarin and its fractions.Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.Glycyrrhizin as antiviral agent against Hepatitis C Virus.Hepatitis C virus to hepatocellular carcinoma.Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CBetulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression.Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaHepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies.Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation.Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals.Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patientsViruses as key regulators of angiogenesis.Exploitation of lipid components by viral and host proteins for hepatitis C virus infection.Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.Pharmacogenomics of cyclooxygenases.The role of HCV proteins on treatment outcomes.Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt.Classical swine fever virus NS5A protein localizes to endoplasmic reticulum and induces oxidative stress in vascular endothelial cells.Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.
P2860
Q26826958-ABACCB75-B00F-46B2-A79A-F10C494BD915Q27481487-2A25BF4D-6B7D-42EB-9717-88BFAD1F01C3Q28221273-B5F5CE10-1F37-43E1-87EA-306F46533E88Q33263605-B0F0CD24-F58A-418B-A0B3-EA139FFAC12CQ34423461-F0C8CAB1-2FEC-475A-9CCA-06D152443B7AQ34499002-FB7F00F8-3914-46BD-B853-945DC4C120F9Q34506147-A8D7AE32-EF19-49B2-8690-27A2A04B748CQ34568343-92741916-5106-474C-8CB7-368C4FB1EDEFQ34612360-8A191898-8EDC-48A4-B18D-4420DBD26BB5Q34617749-6D69E4FE-9D21-47F0-8E6F-1AFCA6229B13Q34732677-5562D2EE-A1E4-4BA7-93AB-EBAF7918DEA6Q34750481-7B5B6F61-1253-4149-B7A4-AE0A85D6BC98Q34756135-AEF689FA-738E-4A3C-A37E-FE287AF654C1Q34809056-95418F8F-1AD4-4451-80B9-192755C4744AQ34832969-64670028-D045-4F80-A815-86CD66C85132Q35203744-92A1C88C-7BFB-4EAD-8112-14AC87100083Q35800315-15541E90-7606-4036-B1BE-AD5E20DEA261Q35810531-8ECF0EC3-E2D7-435D-886D-18A261170C71Q36036224-DBCA7B81-CD40-42FB-B1EE-83E40F991989Q36143166-869B5E67-08A5-4D50-93BC-97D30AAF39ACQ36397362-E5512220-E1A6-41F6-A368-AFE897CA059BQ36854662-2A8EE068-F05B-41CE-A882-36DDD50881EBQ37138984-C6F4BDC7-B6EC-4DC2-BAC0-C52208E0215FQ37252579-32BA9999-4499-48DE-A75E-DE316B15E38DQ37434796-DB8A47A1-D141-40C6-A83F-398129FBC035Q37521412-15869F35-CA82-4FBB-83B0-F92BB720E050Q37621796-F12A98FF-C603-47CB-9B14-ABA733BD11D4Q37634828-D4B8ABE4-6613-4D4B-A79F-A5C61F1EB57FQ37871527-46298F4D-4EBC-4311-8D2B-8AAA79D7C794Q37986051-00704E56-B50C-4754-B112-5F3011B76B94Q38157936-A0711F6E-195F-4448-85C2-FD0022D315C9Q38248404-2FF6FC3C-1F36-4392-A9D9-05A0A8A6594EQ38444433-71047210-BE03-45F4-8534-71C0ADD58D86Q38668968-899C6148-68A4-4C16-9567-AA5398D78443Q38876354-9E5DE29D-B417-4843-B2BE-BA791A2DEB65Q38892529-556EAEB4-F215-4235-B284-85FA6525F4BDQ39258273-85C30D1B-7173-4185-9CC7-3D895CA5D38CQ39327821-0D79DBF4-EF14-4404-901C-BAEA29C10294Q39340978-B7165B2B-8281-4030-8D40-E6AD155DDDD9Q39520749-330B03F1-D75E-443D-8BF3-B9312CB3894C
P2860
Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@ast
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@en
type
label
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@ast
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@en
prefLabel
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@ast
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@en
P2093
P2860
P356
P1433
P1476
Increased intrahepatic cycloox ...... f viral core and NS5A proteins
@en
P2093
A Apolinario
A Fernández-Martínez
C García-Monzón
G Clemente
I Benedicto
M Gómez-Gonzalo
M López-Cabrera
P L Majano
P2860
P304
P356
10.1136/GUT.2003.038364
P407
P577
2004-11-01T00:00:00Z